Product Information
LEUPROLIDE 2WK 14 MG/2.8 ML KT is a generic product labeled by Sun Pharmaceutical Industries Inc., priced at $197.6060 per EA under NDC 47335093640. Its NADAC has been published 110 times since Apr 17, 2024.
FDA first approved this application on Mar 9, 2009. Its Orange Book therapeutic-equivalence code is AP.
Manufacturer
Sun Pharmaceutical Industries Inc.NDC
47335093640
Classification
Generic
Dosage Form
KIT
Effective Date
5/27/2026
Approval Type
Generic (ANDA)
FDA Application
ANDA078885FDA Approved
3/9/2009
TE Code
AP
On Market Since
12/15/2014
Price Statistics
The NADAC for LEUPROLIDE 2WK 14 MG/2.8 ML KT has been published 110 times since Apr 17, 2024, and over the history we have for it it has declined 14.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $197.6060 per EA |
|---|---|
| All-time high | $301.8717 (Sep 10, 2025) |
| All-time low | $197.6060 (May 27, 2026) |
| 52-week high | $301.8717 |
| 52-week low | $197.6060 |
| Median price | $259.0562 |
| Average price | $257.5799 |
| Largest weekly change | +23.4% (Aug 21, 2024) |
| Weeks tracked | 110 |
| Tracking since | Apr 17, 2024 |
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of LEUPROLIDE 2WK 14 MG/2.8 ML KT?
The current National Average Drug Acquisition Cost (NADAC) for LEUPROLIDE 2WK 14 MG/2.8 ML KT, manufactured by Sun Pharmaceutical Industries Inc., is $197.6060 per EA (NDC 47335093640), effective Aug 19, 2026.
How has the price of LEUPROLIDE 2WK 14 MG/2.8 ML KT changed over time?
Over the history we have for it, the NADAC for LEUPROLIDE 2WK 14 MG/2.8 ML KT has declined 14.2%. It has been tracked across 110 weekly CMS publications since Apr 17, 2024.
What are the highest and lowest recorded NADAC prices for LEUPROLIDE 2WK 14 MG/2.8 ML KT?
Since Apr 17, 2024, the NADAC for LEUPROLIDE 2WK 14 MG/2.8 ML KT has ranged from a low of $197.6060 (May 27, 2026) to a high of $301.8717 (Sep 10, 2025), with a median of $259.0562 per EA.
Are there cheaper alternatives to LEUPROLIDE 2WK 14 MG/2.8 ML KT?
4 manufacturers publish a NADAC-priced product with the same active ingredient and strength as LEUPROLIDE 2WK 14 MG/2.8 ML KT in a comparable dosage form, but none are currently priced below it.
Who manufactures LEUPROLIDE 2WK 14 MG/2.8 ML KT?
LEUPROLIDE 2WK 14 MG/2.8 ML KT (NDC 47335093640) is labeled by Sun Pharmaceutical Industries Inc., and CMS classifies it as a generic product.